Everest Clinical Research

Everest Clinical Research's Services

Everest Clinical Research offers a comprehensive suite of clinical research services tailored to the needs of the pharmaceutical, biotechnology, and medical device industries. Their expertise spans Biostatistics and Statistical Programming, Clinical Data Management, DMC/DSMB Administration, Interactive Response Technologies (IRT), Clinical Project Management and Operations, Pharmacovigilance/Drug Safety, Medical and Scientific Writing, Clinical Pharmacology and Drug Development, Regulatory Consultation and Submissions, and Functional Service Provider (FSP). This broad range of services underscores Everest's commitment to supporting the entire lifecycle of clinical trials, from planning and execution to regulatory submissions and post-marketing surveillance.

Everest Clinical Research's Global Presence

Everest Clinical Research maintains a robust global presence with offices in Toronto, Canada; New Jersey, USA; Shanghai, China; Taipei, Taiwan; and Sofia, Bulgaria. This extensive geographical footprint enables them to efficiently manage and oversee multinational clinical trials, ensuring adherence to local regulatory requirements and facilitating smooth operations across different regions. The company's strategic locations help them cater to a diverse client base and support the global reach of their services.

Everest Clinical Research's Acquisitions

In recent years, Everest Clinical Research has expanded its capabilities and market reach through strategic acquisitions. In December 2022, they acquired Brightech International, a New Jersey-based CRO specializing in Biometrics services. This acquisition bolstered Everest's expertise in biostatistics and data management. Furthermore, in November 2023, Everest acquired August Research, a European CRO focused on Clinical Operations and Pharmacovigilance services. These acquisitions have strengthened Everest's service offerings and enhanced their ability to deliver high-quality, comprehensive clinical research solutions.

Everest Clinical Research's Commitment to Quality

Everest Clinical Research is dedicated to maintaining the highest standards of quality and customer service. They employ a robust Quality Management System (QMS) that includes ISO 9001:2015 certification, ensuring consistent and reliable service delivery. Since their inception in January 2004, Everest has successfully passed over 150 on-site and remote sponsor and regulatory agency audits/inspections, reflecting their commitment to excellence and regulatory compliance. Their repeat customer rate, maintained at over 95% throughout the company's history, is a testament to their quality-focused approach and client satisfaction.

Everest Clinical Research's Technological Advancements

Everest Clinical Research leverages advanced technologies to enhance their clinical research services. They utilize Electronic Data Capture (EDC) Systems, SAS and other statistical analysis tools, Phoenix WinNonlin and NONMEM for pharmacokinetic/pharmacodynamic modeling, Interactive Response Technologies (IRT) for randomization and trial supply management, Oracle Argus for safety data management, and various medical writing and publishing tools. Additionally, they employ electronic regulatory submission (eCTD) tools and processes, ensuring compliance with 21 CFR Part 11 requirements for electronic records and signatures. These technologies enable Everest to deliver efficient, accurate, and compliant clinical research solutions.